Analyst Consensus ?
ConsensusBuy38 ratings
Bullish2873.7%
Neutral1026.3%
Bearish00.0%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Generac Holdings Inc. complete analyst coverage
Generac Holdings Inc. (GNRC) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$198.81Current
$75Low
$261.4Average
$460High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Stifel | Buy | Buy | Maintain | Jul 30, 2026 |
| Needham | Buy | Buy | Maintain | Jul 30, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Jul 30, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 30, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 2, 2026 |
| UBS | Buy | Buy | Maintain | Jun 11, 2026 |
| Jefferies | Buy | Hold | Upgrade | May 22, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | May 21, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | May 1, 2026 |
| TD Cowen | Buy | Buy | Maintain | Apr 30, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 30, 2026 |
| Argus Research | Buy | Buy | Maintain | Apr 30, 2026 |
| B of A Securities | Buy | Buy | Maintain | Mar 26, 2026 |
| Guggenheim | Neutral | Buy | Downgrade | Feb 12, 2026 |
| Baird | Outperform | Neutral | Upgrade | Jan 9, 2026 |
| Roth Capital | Neutral | Neutral | Maintain | Jul 22, 2025 |
| TD Securities | Buy | Buy | Maintain | May 1, 2025 |
| Piper Sandler | Overweight | Overweight | Maintain | Apr 17, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Feb 13, 2025 |
| Truist Securities | Buy | Buy | Maintain | Jan 16, 2025 |
| Roth MKM | Neutral | Neutral | Maintain | Oct 22, 2024 |
| Northland Capital Markets | Outperform | Outperform | Maintain | Aug 1, 2024 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Jul 29, 2024 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Jun 13, 2024 |
| Oppenheimer | Outperform | Outperform | Maintain | May 2, 2024 |
| OTR Global | Positive | Mixed | Upgrade | Apr 2, 2024 |
| William Blair | Outperform | Outperform | Maintain | Jul 6, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 2, 2023 |
| Keybanc | Overweight | Downgrade | Oct 20, 2022 | |
| Cowen & Co. | Outperform | Outperform | Maintain | Sep 30, 2022 |
| Colliers Securities | Buy | Buy | Maintain | Dec 15, 2021 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Feb 12, 2021 |
| Bank of America | Neutral | Buy | Downgrade | Nov 1, 2019 |
| Northcoast Research | Buy | Neutral | Upgrade | May 3, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Aug 2, 2018 |
| SunTrust Robinson Humphrey | Buy | Hold | Upgrade | Feb 14, 2018 |
| Wolfe Research | Perform | Peer Perform | Maintain | Jul 11, 2017 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 12, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $198.81. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Roth Capital | Analyst unavailable | $214 | $192.3 | +7.6% | Jul 30, 2026 |
| D.A. Davidson | Analyst unavailable | $333 | $192.85 | +67.5% | Jul 30, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $333 | $196.07 | +67.5% | Jul 30, 2026 |
| Robert W. Baird | Analyst unavailable | $305 | $191.26 | +53.4% | Jul 30, 2026 |
| Needham | Analyst unavailable | $283 | $195.19 | +42.3% | Jul 30, 2026 |
| Stifel Nicolaus | Stephen Gengaro | $285 | $195.19 | +43.4% | Jul 30, 2026 |
| Barclays | Analyst unavailable | $278 | $195.19 | +39.8% | Jul 30, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $325 | $215.61 | +63.5% | Jul 22, 2026 |
| Barclays | Analyst unavailable | $285 | $278.62 | +43.4% | Jun 29, 2026 |
| UBS | Analyst unavailable | $335 | $239.11 | +68.5% | Jun 11, 2026 |
| Jefferies | Analyst unavailable | $302 | $247.79 | +51.9% | May 22, 2026 |
| Raymond James | Tanner James | $302 | $247.79 | +51.9% | May 22, 2026 |
| UBS | Analyst unavailable | $305 | $263 | +53.4% | May 5, 2026 |
| Stephens | Analyst unavailable | $290 | $257 | +45.9% | May 1, 2026 |
| Roth Capital | Chip Moore | $257 | $254.23 | +29.3% | Apr 30, 2026 |
| Argus Research | John Eade | $290 | $257.78 | +45.9% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $275 | $256.29 | +38.3% | Apr 30, 2026 |
| Canaccord Genuity | Analyst unavailable | $325 | $252.92 | +63.5% | Apr 30, 2026 |
| Robert W. Baird | Analyst unavailable | $311 | $252.92 | +56.4% | Apr 30, 2026 |
| Barclays | Christine Cho | $228 | $194.4 | +14.7% | Mar 27, 2026 |
| UBS | Jon Windham | $270 | $215.04 | +35.8% | Feb 13, 2026 |
| Barclays | Analyst unavailable | $213 | $223.72 | +7.1% | Feb 12, 2026 |
| Stifel Nicolaus | Analyst unavailable | $235 | $221.67 | +18.2% | Feb 12, 2026 |
| Roth Capital | Analyst unavailable | $220 | $214.99 | +10.7% | Feb 12, 2026 |
| Robert W. Baird | Michael Halloran | $292 | $214.99 | +46.9% | Feb 12, 2026 |
| Canaccord Genuity | Analyst unavailable | $275 | $214.99 | +38.3% | Feb 12, 2026 |
| Barclays | Analyst unavailable | $186 | $160.85 | -6.4% | Jan 20, 2026 |
| Canaccord Genuity | Analyst unavailable | $236 | $156.6 | +18.7% | Jan 13, 2026 |
| Robert W. Baird | Analyst unavailable | $199 | $148.79 | +0.1% | Jan 9, 2026 |
| Wells Fargo | Analyst unavailable | $195 | $136.99 | -1.9% | Dec 19, 2025 |
| Barclays | Analyst unavailable | $197 | $165.78 | -0.9% | Oct 31, 2025 |
| UBS | Analyst unavailable | $215 | $174.3 | +8.1% | Oct 30, 2025 |
| Roth Capital | Chip Moore | $184 | $180.86 | -7.4% | Oct 30, 2025 |
| Needham | Analyst unavailable | $248 | $183.96 | +24.7% | Oct 22, 2025 |
| Guggenheim | Analyst unavailable | $202 | $168.3 | +1.6% | Oct 9, 2025 |
| Barclays | Analyst unavailable | $188 | $165.67 | -5.4% | Oct 6, 2025 |
| Canaccord Genuity | Analyst unavailable | $240 | $164.26 | +20.7% | Sep 25, 2025 |
| UBS | Jon Windham | $220 | $181 | +10.7% | Jul 31, 2025 |
| Barclays | Analyst unavailable | $200 | $181 | +0.6% | Jul 30, 2025 |
| Stifel Nicolaus | Stephen Gengaro | $175 | $165.55 | -12.0% | Oct 31, 2024 |
| Truist Financial | Jordan Levy | $210 | $165.55 | +5.6% | Oct 31, 2024 |
| Goldman Sachs | Jerry Revich | $148 | $165.55 | -25.6% | Oct 31, 2024 |
| Citigroup | Vikram Bagri | $172 | $166.65 | -13.5% | Oct 21, 2024 |
| Piper Sandler | Kashy Harrison | $175 | $146.24 | -12.0% | Sep 24, 2024 |
| Canaccord Genuity | George Gianarikas | $200 | $155.68 | +0.6% | Aug 1, 2024 |
| Truist Financial | Jordan Levy | $170 | $147.8 | -14.5% | May 23, 2024 |
| Oppenheimer | Christopher Glynn | $145 | $127.63 | -27.1% | May 2, 2024 |
| Roth Capital | Chip Moore | $135 | $134.12 | -32.1% | Apr 23, 2024 |
| Canaccord Genuity | George Giankarikas | $150 | $131.34 | -24.6% | Apr 5, 2024 |
| CFRA | Strong Buy | $145 | $125.8 | -27.1% | Feb 7, 2024 |
| Truist Financial | Jordan Levy | $160 | $113.95 | -19.5% | Aug 4, 2023 |
| Canaccord Genuity | George Giankarikas | $175 | $135.54 | -12.0% | Feb 16, 2023 |
| Janney Montgomery | Sean Milligan | $160 | $91.15 | -19.5% | Dec 28, 2022 |
| Roth Capital | Philip Shen | $75 | $110.3 | -62.3% | Oct 20, 2022 |
| Piper Sandler | Kashy Harrison | $305 | $249.79 | +53.4% | Jul 21, 2022 |
| Wells Fargo | Praneeth Satish | $285 | $213.05 | +43.4% | Jun 29, 2022 |
| J.P. Morgan | Mark Strouse | $455 | $259.5 | +128.9% | May 5, 2022 |
| J.P. Morgan | Mark Strouse | $469 | $316.44 | +135.9% | Feb 16, 2022 |
| Bank of America Securities | Ross Gilardi | $350 | $265.19 | +76.0% | Jan 26, 2022 |
| Truist Financial | Tristan Richardson | $425 | $286.19 | +113.8% | Jan 24, 2022 |
| UBS | Jon Windham | $480 | $323.73 | +141.4% | Jan 10, 2022 |
| Piper Sandler | Kashy Harrison | $481 | $316.55 | +141.9% | Jan 7, 2022 |
| Roth Capital | Philip Shen | $555 | $453.4 | +179.2% | Nov 3, 2021 |
| Guggenheim | Joseph Osha | $460 | $409.19 | +131.4% | Jun 28, 2021 |
Track every rating change on GNRC the moment it posts. Free to start.
Start free